Chronic News and Research

RSS

FDA accepts to review sNDA for SPRYCEL for treating adult patients with CML

Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. today announced that the U.S. Food and Drug Administration has accepted for filing and review the supplemental New Drug Application for SPRYCEL (dasatinib) for the treatment of adult patients with newly diagnosed chronic myeloid leukemia in chronic phase.

12 Jul 2010

Diabetes reform plans do not please the AMA

In a bid to reform the way long term illnesses like diabetes are managed in Australia, the federal government announced a $436 million scheme to be introduced from 2012.

11 Jul 2010

News roundup: NYC program to help poor, elderly with insurance gets cut; Colo. promotes wellness programs for small businesses

A program that for a decade helped New York City's poor and elderly navigate their way through insurance problems — and that became a model for a similar federal program — has become a casualty of city budget cuts, an administrator of the program said on Thursday. The $4 million program sent ombudsmen to 25 social service agencies across the city.

9 Jul 2010

New food safety requirements for large-scale egg producers: FDA

The U.S. Food and Drug Administration says that as many as 79,000 illnesses and 30 deaths due to consumption of eggs contaminated with the bacterium Salmonella Enteritidis may be avoided each year with new food safety requirements for large-scale egg producers.

9 Jul 2010

Colgate-Palmolive teams up with a trio of Saints to champion good oral health among Gulf Coast children

Colgate's Bright Smiles, Bright Futures national campaign to improve children's oral health joins Super Bowl champions Jonathan Vilma, Pierre Thomas, and Marques Colston and the Boys & Girls Clubs of Southeast Louisiana and Boys & Girls Clubs of the Gulf Coast, to host festivals highlighting the importance of maintaining good oral health. More than 600 children in New Orleans and Mississippi's Hancock and Harrison Counties will receive free dental screenings, oral health education and treatment referrals this weekend. They will also join New Orleans Saints Vilma, Thomas, and Colston in a brush-a-thon to promote oral health awareness.

9 Jul 2010

Study shows association between obesity and GERD in children

Extremely obese children have a 40 percent higher risk of gastroesophageal reflux disease and children who are moderately obese have a 30 percent higher risk of GERD compared to normal weight children, according to a Kaiser Permanente study published online in the International Journal of Pediatric Obesity.

9 Jul 2010

Community-based wellness program helps reduce obesity, chronic inflammatory diseases: Study

Tackling weight loss, risk of chronic disease and overall well-being as part of a like-minded social community can dramatically influence an individual's success rate, according to a new study published in the July 2010 issue of the Center for Disease Control's Preventing Chronic Disease journal.

9 Jul 2010

Allergan receives UK MHRA authorisation of BOTOX for prophylaxis of headache in chronic migraine

Allergan is pleased to announce that BOTOX® (botulinum toxin type A) has been licensed by the MHRA in the UK for the prophylaxis of headaches in adults who have chronic migraine (headaches on at least 15 days per month of which at least 8 days are with migraine). This is the first licence worldwide of BOTOX® for this indication, and is also the first prophylactic (preventative) treatment to receive a specific licence for patients with chronic migraine.

9 Jul 2010

Fromer-GPF Patient Journey launched to help primary care physicians improve patient care

Group Practice Forum, an independent network of medical professionals, today announced the official launch of the Fromer-GPF Patient Journey, a proprietary workflow solution designed to provide primary care physicians with simple solutions to improve patient care. The Journey was developed by the Executive Medical Director of GPF, Len Fromer, M.D., FAAFP, who also serves as Assistant Clinical Professor of Family Medicine at University of California at Los Angeles School of Medicine and Western University of Health Sciences.

9 Jul 2010

Musashi 2 protein predicts progression of AML and CML, identify researchers

Researchers at Whitehead Institute and Children's Hospital Boston have identified a protein, called Musashi 2, that is predictive of prognosis in acute myeloid leukemia and chronic myeloid leukemia patients.

9 Jul 2010

Patients with advanced Parkinson's disease prefer dopamine agonists, shows review

Of the three main types of oral drugs commonly added to levodopa therapy for patients with advanced Parkinson's disease, one might be the most effective, according to a new review.

9 Jul 2010

Student-led team awarded top honor in 2010 CIMIT Prize in Primary Healthcare competition

Imagine finding out before you leave the pediatrician's office if your child has strep throat, or even something more serious requiring a different treatment. A novel application for applying DNA "nanobarcodes" in a clinical assay could help primary-care physicians quickly and more accurately determine what's causing a patient's acute pharyngitis from an easy throat swab.

9 Jul 2010

Texas Health Presbyterian Hospital Dallas named Center of Excellence for gynecological surgery

Texas Health Presbyterian Hospital Dallas is the first hospital in Texas — and one of only three in the United States — to be named a Center of Excellence for gynecological surgery by the American Institute for Minimally Invasive Surgery.

9 Jul 2010

Dysautonomia linked to CKD: Study

Individuals with a high resting heart rate and a low beat-to-beat heart rate variability have an increased risk of developing kidney disease, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology. The findings suggest that the behavior of the autonomic nervous system may be a sentinel marker for late development of certain cases of kidney disease.

9 Jul 2010

American, Canadian officials discuss global health developments at recent G8, G20 summits

The recent G8 summit in Canada's Muskoka region took an important step forward in improving maternal and child health in developing countries, Canadian and American officials said at a forum Wednesday in Washington, DC.

9 Jul 2010

KHN column -- High-risk pools: A rare opportunity for bipartisanship

In his latest Kaiser Health News column, Harold Pollack writes: "This month a key program created by the new health overhaul law, the Pre-Existing Condition Insurance Plan, becomes operational in many states. Over the next 40 months, this high-risk insurance pool will provide $5 billion to cover Americans who face the dual challenges of chronic illness and uninsurance.

8 Jul 2010

Rockwell Medical completes End of Phase II meeting with FDA regarding SFP

Rockwell Medical, a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease, chronic kidney disease, and iron deficiency anemia, announced today that it has successfully completed an End of Phase II meeting with the U.S. Food and Drug Administration regarding the Company's lead drug candidate Soluble Ferric Pyrophosphate, a novel continuous iron-replacement therapy designed to treat iron deficiency anemia in hemodialysis patients.

8 Jul 2010

WSBI, University of Colorado sign licensing agreement for TCISM targets

Western States Biopharmaceuticals, Inc., a privately-held biotechnology company focusing on the development of novel therapies to treat inflammatory disease, and the University of Colorado announced today that they have entered into a licensing agreement for approaches to inhibiting newly discovered T cell Cytokine Inducing Surface Molecules, or TCISM autoimmune disease drug discovery targets.

8 Jul 2010

First Edition: July 8, 2010

Today's headlines reflect the continued coverage of President Obama's recess appointment of Dr. Donald Berwick to head CMS as well as other developments related to Medicaid, the health insurance industry and state challenges to the health reform law.

8 Jul 2010

Article related to MN-166 mechanism of action included in PNAS USA

MediciNova Inc, a biopharmaceutical company publicly traded on the NASDAQ Global Market and the Hercules Market of the Osaka Securities Exchange (Code Number:4875), today reported that the June 22, 2010 issue of Proceedings of the National Academy of Sciences USA included an article related to the mechanism of action of MN-166 (ibudilast), as an emerging therapeutic for neurological disorders.

8 Jul 2010

Chronic News and Research

FDA accepts to review sNDA for SPRYCEL for treating adult patients with CML

Diabetes reform plans do not please the AMA

News roundup: NYC program to help poor, elderly with insurance gets cut; Colo. promotes wellness programs for small businesses

New food safety requirements for large-scale egg producers: FDA

Colgate-Palmolive teams up with a trio of Saints to champion good oral health among Gulf Coast children

Study shows association between obesity and GERD in children

Community-based wellness program helps reduce obesity, chronic inflammatory diseases: Study

Allergan receives UK MHRA authorisation of BOTOX for prophylaxis of headache in chronic migraine

Fromer-GPF Patient Journey launched to help primary care physicians improve patient care

Musashi 2 protein predicts progression of AML and CML, identify researchers

Patients with advanced Parkinson's disease prefer dopamine agonists, shows review

Student-led team awarded top honor in 2010 CIMIT Prize in Primary Healthcare competition

Texas Health Presbyterian Hospital Dallas named Center of Excellence for gynecological surgery

Dysautonomia linked to CKD: Study

American, Canadian officials discuss global health developments at recent G8, G20 summits

KHN column -- High-risk pools: A rare opportunity for bipartisanship

Rockwell Medical completes End of Phase II meeting with FDA regarding SFP

WSBI, University of Colorado sign licensing agreement for TCISM targets

First Edition: July 8, 2010

Article related to MN-166 mechanism of action included in PNAS USA

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News